[社交媒体中关于食补充剂的错误信息和虚假信息:限制风险,抓住机遇,塑造结构]
Emma C Gauch1, Martin Smollich2
1Institut für Ernährungsmedizin, Universitätsklinikum Schleswig-Holstein, Ratzeburger Allee 160, 23538, Lübeck, Deutschland.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|October 10, 2025
概括
社交媒体提供关于食补充剂 (DSs) 的信息,但也传播有害的错误信息,通常是为了利. 本次审查突出了消费者健康保护的风险和机会,涉及在线DS.
科学领域:
- 营养科学 营养科学
- 公共卫生 公共卫生
- 数字健康传播数字健康传播
背景情况:
- 社交媒体是食补充剂 (DS) 信息的主要来源,但往往传播出经济动机的错误信息.
- 消费者健康保护受到社会平台上未经验证的DS声称的普及的挑战.
- 具体而言,在社交媒体领域,关于DS信息的研究有限.
研究的目的:
- 审查通过社交媒体共享的DS信息的现有数据.
- 确定与DSs相关的消费者健康保护的具体风险和机会.
- 为社交媒体上负责任的DS沟通制定可行的建议.
主要方法:
- 关于社交媒体和食补充剂的研究文献综述.
- 分析信息传播模式和内容.
- 识别消费者保护的挑战和潜在的干预措施.
主要成果:
- 社交媒体平台包含大量的DS信息,其中很大一部分是经济驱动和潜在的误导.
- 关于DS的好处和风险的错误信息和虚假信息对公共健康和知情的消费者选择构成威胁.
- 尽管存在风险,但社交媒体为传播基于证据的DS教育提供了机会.
结论:
- 迫切需要制定策略,以减轻社交媒体上的DS错误信息.
- 制定框架,促进DS消费者的透明度和基于证据的信息.
- 平台,制造商和卫生机构之间的合作对于消费者健康保护至关重要.
相关概念视频
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Drug Control Governance: Regulatory Bodies and Their Impact
491
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
491
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Self-Presentation: Self-Monitoring and Self-Handicapping
43.5K
People can go to great lengths to protect their self-image and present themselves in ways that they want others to see them. Sociologist Erving Goffman presented the idea that a person is like an actor on a stage. Calling his theory dramaturgy, Goffman believed that we use “impression management” to present ourselves to others as we hope to be perceived. Each situation is a new scene, and individuals perform different roles depending on who is present (Goffman, 1959). Think about...
43.5K
Self-Help Support Groups
317
Self-help support groups are voluntary, community-based organizations that provide a platform for individuals with shared concerns to exchange support, insights, and practical strategies for coping with life challenges. Typically led by group members or paraprofessionals, these groups form a cornerstone of mental health care, especially in reaching populations that are underserved by traditional healthcare systems.
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...
317
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
558
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
558


